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Abstract The structure of the chemically synthesized C-
terminal region of the human agouti related protein (AGRP)
was determined by 2D 1H NMR. Referred to as minimized
agouti related protein, MARP is a 46 residue polypeptide
containing 10 Cys residues involved in five disulfide bonds that
retains the biological activity of full length AGRP. AGRP is a
mammalian signaling molecule, involved in weight homeostasis,
that causes adult onset obesity when overexpressed in mice.
AGRP was originally identified by homology to the agouti
protein, another potent signaling molecule involved in obesity
disorders in mice. While AGRP’s exact mechanism of action is
unknown, it has been identified as a competitive antagonist of
melanocortin receptors 3 and 4 (MC3r, MC4r), and MC4r in
particular is implicated in the hypothalamic control of feeding
behavior. Full length agouti and AGRP are only 25%
homologous, however, their active C-terminal regions are
V40% homologous, with nine out of the 10 Cys residues
spatially conserved. Until now, 3D structures have not been
available for either agouti, AGRP or their C-terminal regions.
The NMR structure of MARP reported here can be character-
ized as three major loops, with four of the five disulfide bridges at
the base of the structure. Though its fold is well defined, no
canonical secondary structure is identified. While previously
reported structural models of the C-terminal region of AGRP
were attempted based on Cys homology between AGRP and
certain toxin proteins, we find that Cys spacing is not sufficient
to correctly determine the 3D fold of the molecule.
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1. Introduction
Recent biochemical investigations have identi¢ed agouti re-
lated protein (AGRP) as playing a major role in the regula-
tion of mammalian feeding behavior. AGRP is a naturally
occurring competitive antagonist of melanocortin receptors 3
and 4 (MC3r and MC4r), the overexpression of which results
in adult onset obesity and diabetes in mice [1^3]. AGRP bind-
ing to MC4r in particular is the subject of intense interest
since knockout mice that do not express MC4r exhibit the
same phenotype as caused by overexpression of AGRP [2].
There is also evidence for the parallel expression of AGRP
and neuropeptide Y in the arcuate nucleus of the hypothal-
amus, with neuropeptide Y known to stimulate feeding [3].
This region of the brain also expresses MC4r and is involved
in energy homeostasis.
The growing body of evidence linking AGRP to weight
control has yet to elucidate its exact mechanism of action.
However, studies on AGRP do bene¢t from analogy to the
much more widely studied agouti protein, as AGRP was orig-
inally identi¢ed through the homology of its C-terminal re-
gion with the same region of the agouti protein [1]. The agouti
protein has been a focal point in obesity research for a num-
ber of years, since ectopic expression of the wild-type protein
in mice leads to obesity and related disorders, i.e. the same
symptoms as the overexpression of the more recently identi-
¢ed AGRP [4,5]. However, unlike AGRP, agouti has distinct
expression patterns in mice and humans [6], making in vivo
work with mice less applicable to human obesity disorders.
AGRP, like agouti, is selective for MC3r and MC4r but has
approximately 100-fold greater binding a⁄nity than agouti at
these receptors [7].
While full length agouti and AGRP are only 25% homolo-
gous, in their 46 residue Cys-rich C-terminal regions nine of
the 10 Cys residues are spatially conserved and there are a
further 10 identical residues giving V40% sequence identity.
Three consecutive, conserved residues RFF (111^113 in hu-
man AGRP) were determined to be essential to the biological
activity of both agouti [8,9] and AGRP [10]. Two recent in-
vestigations have shown that the chemically synthesized C-
terminal region of AGRP competitively antagonizes K-mela-
nocyte stimulating hormone (K-MSH) at melanocortin recep-
tors with equal or greater potency than the full proteins
[11,12], consistent with similar ¢ndings for agouti [13]. Thus
the C-terminal region of AGRP (MARP, Fig. 1) is a prime
candidate for structural studies.
Despite the important biological activities of AGRP, no
experimental 3D structure is available for this protein. The
inhibitor cystine knot (ICK) family of proteins are also disul-
¢de-rich and the structures of these invertebrate toxins have
been used to suggest possible structures for the agouti and
AGRP C-terminal regions [9,10]. Indeed, the recently reported
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disul¢de map for AGRP and a construct containing the C-
terminal domain demonstrates ICK-like pairings [14] of the 10
Cys residues: 1-16, 8-22, 15-33, 19-43, 24-31 (using MARP
numbering, see below) [15]. Beyond such modeling, the only
structural data published on either agouti or AGRP are cir-
cular dichroism (CD) spectra which suggest that both proteins
have little regular secondary structure, although there may be
some L-sheet, consistent with ICK structural characteristics
[13,16].
In this paper we report the 3D structure in solution of the
human AGRP Cys-rich, C-terminal region as determined by
1H NMR using protein prepared by total chemical synthesis.
Because biochemical investigations demonstrate that this min-
imal region retains full biological activity, we refer to this
protein as minimized agouti related protein, MARP (human
AGRP residues 87^132). The protein’s topology is character-
ized by three large loops and an absence of canonical second-
ary structure such as helices or sheets. Two of the three loops
are structurally well characterized by the NMR data as indi-
cated by low RMSDs. The region of MARP containing the
RFF triplet [10] (residues 25^27 in MARP) necessary for
function is located in one of the best de¢ned regions of the
protein. Despite the conservation of Cys spacing and the di-
sul¢de map between MARP and other small disul¢de-rich
proteins from the ICK family, it is apparent from the struc-
ture reported here that MARP does not adopt an ICK-like
fold.
2. Materials and methods
2.1. Chemical protein synthesis
NK-Acetyl-MARP and NK-acetyl-MARP(Arg25Ala) were synthe-
sized, folded and puri¢ed to each give a protein containing ¢ve disul-
¢de bonds, as reported previously [12]
2.2. CD experiments
CD spectra were recorded at 25‡C on an Aviv 60DS spectropol-
arimeter in a rectangular 1 mm path length cuvet for concentrations
up to 60 WM, for concentrations higher than this a round cell with a
0.1 mm path length was used. All CD samples were 50 mM potassium
phosphate, pH 4.25. Concentration dependence was ruled out in the
range 20 WM^1 mM. Temperature dependence was determined for 5^
85‡C. The spectra are superimposable from 5 to 45‡C.
2.3. NMR sample preparation
The activity of MARP used for the NMR sample and that of a
single mutant were assayed by measuring the inhibition of cAMP
production in the presence of [Nle4,D-Phe7]K-MSH (NDP-MSH)
[12] in HEK-293 cells transfected with human MC4r. Control experi-
ments were performed with no MARP. The NMR samples were
found to be native-like with complete activity. NMR samples con-
tained approximately 1.9 mM MARP at pH 4.2 in 50 mM KH2PO4
bu¡er in 90% H2O/10% D2O. Additional samples for hydrogen-deu-
terium exchange (HX) experiments were prepared by lyophilization of
protonated samples followed by reconstitution in 700 Wl D2O.
2.4. NMR experiments
1H 2D NMR spectra were principally acquired at 15‡C on a Varian
500 Unity Plus spectrometer using inverse probes. NMR data were
routinely acquired with a 6000 Hz spectral width, 4096 complex
points in t2 and 512 (TOCSY/DQF-COSY) or 700 (NOESY) incre-
ments in t1. All spectra were processed using the MNMR package
(Carlsberg Laboratory, Department of Chemistry, Denmark) and an-
alyzed using XEASY [17], with chemical shifts referenced to 1,4-diox-
ane at 3.743 ppm. Sequential assignments of all backbone and s 90%
of side chain protons were accomplished using standard methods
[18,19] for 50 ms TOCSY, 150 ms NOESY and DQF-COSY data.
Additional data sets were acquired at 25‡C and 30‡C to resolve am-
biguities. Examination of the three Pro residues identi¢ed nOes con-
sistent only with trans-Pro. Four additional peaks were identi¢ed in
the KN region of the TOCSY spectrum, however, associated spin
systems could not be identi¢ed and neither could nOes to the peaks
in question.
NOESY data for distance restraints were collected at 15‡C using
the WET sequence [20] for water suppression, 1.6 s recycle delay and
a mixing time of 80 ms in both H2O and D2O. 3JHNK coupling con-
stants at 25‡C were determined by both linear least squares ¢tting of
the antiphase doublets in a DQF-COSY and also using the INFIT
[21] module of XEASY with 150 ms NOESY data. These methods
agreed to within þ 0.5 Hz for all of the measured coupling constants.
At 15‡C larger intrinsic linewidths precluded accurate measurement of
3JHNK.
For amide exchange experiments, the magnet was preshimmed on a
21 residue peptide sample at pH 4 in D2O/phosphate bu¡er. The ¢rst
TOCSY experiment was begun 23 min after reconstituting the proto-
nated sample in D2O. Four TOCSY experiments identical to those
described above, except for the number of t1 increments, were ac-
quired back to back at 15‡C over a period of 24 h. The ¢rst three
consisted of 150 t1 increments and the ¢nal experiment 300 incre-
ments. NOESY and DQF-COSY spectra were also acquired as de-
scribed above.
2.5. Structure calculations
Final structure calculations included the covalent connectivity of
the published disul¢de map [15], and were based on a total of 414
interproton distance constraints derived from the 80 ms 2D NOESY
spectra and 34 backbone x dihedral angle constraints derived from
coupling constant measurements, giving a total of 448 total restraints,
or 9.7 restraints per residue. The distance restraints can be broken
down into 228 intraresidue (backbone to side chain only), 129 sequen-
tial, 20 medium range (16 di3jd9 5) and 37 long range (di3jds 5)
restraints. These restraints were assigned as strong, medium or
weak. The total numbers of restraints in each category were 95 strong,
246 medium, and 77 weak. All categories had a lower limit of 1.6 Aî ,
with upper limits of 2.8, 3.5 and 5 Aî for the strong, medium and weak
categories, respectively. Trial structures were generated using the sim-
ulated annealing protocol from CNS version 0.4a (anneal.inp) with
SUM averaging for the nOe distances [22326]. Twenty structures with
no bond or nOe angle violations were used to represent the solution
structure of MARP (see Table 1 for RMSDs). Structures were dis-
played using MOLMOL [27].
3. Results
3.1. Chemical synthesis and characterization of MARP
The synthesis and biochemical characterization of MARP
were previously reported [12]. The N-terminal residue (Cys-1)
of MARP corresponds to the ¢rst Cys (Cys-87) of the Cys-
rich region (Fig. 1) in full length, 132 residue human AGRP.
The material used for MARP NMR sample shows native-like
activity as measured by its ability to competitively inhibit
NDP-MSH at MC4r (Fig. 2a), as has been shown in previous
studies [12,28]. Previous mutational studies of agouti and
AGRP showed residues Arg-25, Phe-26, Phe-27 (the RFF
triplet [10]) and Asp-17 (in agouti) to be determinants of
receptor binding [8^10]. In the work reported here, the re-
placement of Arg-25 by Ala results in a complete loss of
inhibitory activity (Fig. 2a).
The far-UV CD spectrum of MARP in Fig. 2b is similar to
that reported for a similar C-terminal fragment (85^132) of
Fig. 1. Covalent structure of MARP, corresponding to the Cys-rich
C-terminus of the human agouti related protein. (Human AGRP
numbering is obtained by adding 86 to MARP numbering.) Disul-
¢de bonds are indicated by lines joining Cys residues [15].
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AGRP reported elsewhere [16] and is characterized by a neg-
ative maximum at approximately 198 nm and a slight negative
maximum at 245 nm. There is little indication of canonical K-
helix, however the spectrum does perhaps suggest some L
character or turns. The near-UV CD spectrum (not shown),
indicative of tertiary structure, shows a weak minimum at
approximately 275 nm which can be attributed to the disul¢de
bonds and possibly restricted orientations of the side chains of
the Tyr-23 and Tyr-32.
At 25‡C between 20 WM and 1.0 mM there is no observable
concentration dependence as measured by CD. Between 1 mM
and 1.9 mM there are no concentration dependent changes
in the NMR spectra (i.e. linewidths, chemical shifts, etc. all
remain constant). The far-UV CD spectrum remains constant
between 5‡C and 45‡C (Fig. 2b), a temperature range well
beyond that of the present NMR experiments. Thus, by all
indications, MARP exists as a monomer and does not exhibit
temperature dependence under the conditions of the NMR
experiments. The characteristics of the NMR spectra are in-
dicative of a well folded protein with a single predominant
conformer. 3JNHK coupling constants and temperature coe⁄-
Fig. 3. CK backbone of the MARP minimized average structure. The N-terminal loop is in green, central loop in red, C-terminal loop in blue.
Disul¢de bonds are represented by dashed lines. Spheres represent residues with amides protected from HX, cyan s 12 h, yellow s 24 h and
magenta s 8 days.
Fig. 2. a: Inhibition of NDP-MSH stimulated cAMP generation in
cells transfected with MC4r. Control experiment with no MARP
(a) ; MARP added (5.0U1036 M) demonstrating competitive inhibi-
tion of NDP-MSH (7) ; MARP with Arg-25 to Ala substitution
added (5.0U1036 M) demonstrating loss of inhibition due to a mu-
tation in the active loop (O). b: Far-UV CD spectra of MARP in
50 mM phosphate bu¡er at pH 4.25 as a function of temperature
with spectra shown every 5‡C from 5‡C to 30‡C and also at 45‡C.
6
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cient also indicate a fully folded, non-random coil conformer
(see Appendix).
3.2. Structural description of MARP
The minimized average NMR structure of MARP is shown
in Fig. 3. Consistent with the far-UV CD spectrum, MARP
shows little evidence of helix or sheet secondary structure. The
disul¢de bonds (1-16, 8-22, 15-33, 19-43 and 24-31) appear to
form a sca¡old upon which the structure is apportioned into
three major loops, which we refer to as the N-terminal loop
(residues 1^18), the central loop (residues 19^34) and the C-
terminal loop (residues 35^46) which are indicated by di¡erent
colors in Fig. 3. RMSDs for the individual loops are reported
in Table 1. The N-terminal and central loops are much better
de¢ned both within the loops and with respect to each other
than the C-terminal loop. The backbone RMSD for the entire
protein (2.54 Aî ) is of the same order as that of the C-terminal
loop (2.36 Aî ), while the backbone RMSD for residues 1^34
(1.66 Aî ) is of the order of the individual N-terminal and
central loops. To demonstrate limited backbone structure var-
iability of the N-terminal and central loops, a superposition of
14 structures (selected for clarity) for residues 1^34 and the
MARP minimized average structure (residues 1^46) is shown
in Fig. 4.
Four of the ¢ve disul¢de bonds are located at the base of
the structure where they appear to pinch together the bottoms
of the loops to form the ‘core’ of the protein (Fig. 3). The
exception is disul¢de bond 24-31 which stabilizes the central
loop. The central loop, residues 19^34, contains the RFF
triplet determined to be critical for activity. This motif is
situated within an even smaller, well de¢ned loop bound by
Cys-24 and Cys-31 which we refer to as the ‘active’ loop. The
side chain atoms of the RFF triplet residues are located at the
surface of the protein as depicted in Fig. 5. Recent experi-
ments further highlight the importance of this active loop.
These studies demonstrate that short cyclic peptides corre-
sponding to residues 24^31 of human AGRP do in fact an-
tagonize MC3r and MC4r [10].
Inspection of the family of NMR structures and consider-
ation of the observed HX (Fig. 6) reveal a structure for the
central loop that can be best described as an irregular hairpin
with a well de¢ned loop from Cys-24 to Cys-31 (RMSD 0.6 Aî
Fig. 5) and a stem region which is both twisted around and
curved along its z-axis (Fig. 3). This characterization is sup-
ported by critical examination of the nOe, 3JHNK and chemical
shift data (Fig. 6). As shown in Fig. 5, the active loop is
highly constrained with the RFF triplet side chains exposed
to solvent. Arg-25 and Phe-27 point out into the solvent,
while one face of the Phe-26 aromatic ring rests parallel
against the surface of the protein. Though the active loop
satis¢es several of the determinants for an 6-loop [29], the
side chain orientation of Arg-25 and Phe-27 precludes its def-
inition as such since 6-loop side chains generally pack within
the loop of backbone atoms.
HX experiments demonstrate that the amide protons of
residues Cys-8, Ala-20, Thr-1, Tyr-23, Tyr-2, Cys-3 and
Arg-34 are protected from exchange with solvent. To explore
whether these results are consistent with the average structure
in Fig. 3, the program DSSP [30] was used to identify poten-
tial hydrogen bonds. DSSP identi¢ed the backbone amides of
Ala-20, Thr-21, Tyr-23, and Arg-34 as potential hydrogen
bond donors. In addition, solvent accessible surface area cal-
culations showed that residues Cys-8 and Cys-33 are com-
pletely buried from solvent, though in the D2O spectrum
the KN crosspeaks of these two residues overlap, thus their
individual protection from exchange is uncertain. Tyr-32 has
only 8% solvent accessible surface area at the CN protons.
The NMR structure gives a well resolved fold, however, as
Table 1
Summary of MARP backbone and heavy atom RMSDs
Region (residues) Backbone RMSDa (Aî ) Heavy atom RMSDa (Aî )
Global (1-46) 2.54 3.26
N- and active loops (1^34) 1.66 2.38
N-terminal loop (1^18) 1.31 2.03
Central loop (19^34) 1.51 2.22
Active loop (24^31) 0.69 1.53
C-terminal loop (35^46) 2.36 3.43
aDetermined by ¢tting the family of 20 NMR structures to the minimized average structure.
Fig. 4. All atom backbone representation of MARP for 14 NMR
structures with residues 1^34 ¢t to the minimized average structure
(RMSD 1.49 Aî ). Only the minimized average structure (thick cylin-
der) is shown for the more disordered C-terminal loop.
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mentioned previously, canonical helices and L-sheets were not
identi¢ed on the basis of nOes or other protocols including
the chemical shift index [31] or 3JNHK coupling constants [18].
The guidelines for these protocols assign secondary structure
on the basis of four or more consecutive residues with similar
conformational shifts or 3JHNK. Helical structure is character-
ized by 3JHNK6 6 Hz and negative conformational shifts and
L-sheet by 3JHNKs 8 Hz and positive conformational shifts.
As shown in Fig. 6, even in the active loop and stem region of
the central loop, no regular secondary structure is identi¢ed
by these criteria. However, the chemical shift index points
towards a possible extended strand from residue 31 to residue
35.
4. Discussion
The 3D structure of MARP is characterized by three loops
held together at the base by an apparent sca¡old of four
disul¢de bonds 1-16, 8-22, 15-33 and 19-43. The ¢fth disul¢de
bond, 24-31, further stabilizes the base of the active loop
which presents the RFF triplet on the protein surface. There
is no identi¢able canonical helical or sheet structure. It is clear
from biochemical data that the RFF triplet is critical for the
activity of MARP as a competitive antagonist of K-MSH
stimulated activation of MC4r signaling. The structure pre-
sented here shows that MARP is structured to present the side
chains of the RFF triplet on the surface of the protein and to
the surrounding solvent. Recent work demonstrates that
MARP is much more active than smaller AGRP derived pep-
tides containing the RFF triplet [10]. Thus, the detailed fold
of the central loop and perhaps the presence of the N- and C-
terminal loops are critical for AGRP function. In addition,
based on work with chimeras of melanocortin receptors (I.
Fig. 5. Backbone atoms for residues 24^31 of the family of 20 structures with residues 24^31 ¢t to the minimized average structure. The side
chain heavy atoms of residues 25, 26 and 27, essential for activity, are shown.
Fig. 6. nOe diagram for the central loop and £anking residues from
the 80 ms NOESY data. For sequential nOes the height of the bar
indicates the strength of the nOe, dashed lines indicate overlapping
nOes. For all other nOes, only non-sequential non-overlapping nOes
are reported, intensity is not indicated. For 3JNHK up arrows indi-
cate Js 8 Hz, down arrows J6 6 Hz and horizontal arrows
66 J6 8 Hz. For chemical shift index (CSI) up arrows indicate
vNHKs 0.1 ppm, down arrows vNHKs d30.1d ppm, horizontal arrows
0.1 ppm6vNHK6 d30.1d ppm. For HX, open circles represent HX
protection for s 12 h, gray circles s 24 h and black circles s 8
days.
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Gantz, unpublished data), it is possible that the N- and C-
terminal loops may confer receptor subtype speci¢city. Fur-
ther work is needed to support this hypothesis.
The previous absence of structural data on both AGRP and
agouti encouraged the modeling of the C-terminal regions of
these proteins onto the ICK family [14] which is characterized
by homologous Cys spacing [9,10]. The ICK family of pro-
teins primarily consists of small (6 60 residues) disul¢de-rich
(three or four disul¢des) toxin proteins from the venom of
spiders and cone snails, which function as ion channel antag-
onists [14]. The coincidence between the function of the ma-
jority of these toxins and the recent description of part of the
agouti protein’s mechanism of action being calcium dependent
[32^34] further encouraged these homology modeling e¡orts.
The ICK motif in particular is characterized by the topology
of the three disul¢de bonds corresponding to 1-16, 8-22 and
15-33 in MARP. In the ICK motif the ¢rst two disul¢de
bonds with their intervening main chain atoms form a topo-
logical circle through which the third disul¢de bond passes,
forming the cystine knot [14]. The motif is further character-
ized by the identi¢cation of an irregular triple stranded anti-
parallel L-sheet, roughly corresponding to residues 6^8, 20^24
and 31^34 in MARP. The remaining two disul¢de bonds in
MARP each occur in individual ICK proteins as separate
examples of potential ‘non-motif’ disul¢de bonds (though it
should be noted that so far there are no examples of ICK
motif proteins with ¢ve disul¢de bonds).
Despite these apparent similarities, the experimental struc-
ture of MARP shows that this protein does not satisfy the
criteria required for inclusion in the ICK family. While the
¢rst two disul¢de bonds in MARP, 1-16 and 8-22, together
with the polypeptide backbone form a topological circle, none
of the remaining disul¢des passes through the circle to form a
cystine knot. Instead, disul¢de bond 15-33 is positioned ad-
jacent to the circle with all of the fold on one side of this
circle. In addition, MARP lacks the L-sheet found in ICK
family proteins. The experimental determination of the dis-
tinctive 3D structure of MARP reported here suggests that
Cys spacing and even the disul¢de map of small Cys-rich
proteins may not always be su⁄cient to accurately predict
protein folds. These results speak to the potential limitations
of ‘homology modeling’ of protein structures, and may have
important implications for the emerging ¢eld of genomic
structural biology.
Acknowledgements: This work was supported by grants from the NIH
(GM46870), the UC Biotechnology Program (97-18) and the Petrole-
um Research Fund (32164-AC4) administered by the ACS. K.A.B.
and G.L.M. thank the donors of the PRF for their support. NMR
instrumentation was supported in part by the Elsa U. Pardee Foun-
dation and a grant from the W.M. Keck Foundation. The authors
wish to thank Mr. Jim Loo for technical assistance in the acquisition
of NMR data and Mr. Eliah Arono¡-Spencer for technical assistance.
Appendix A. Supporting information available
Tables of the 1H chemical shifts at 15‡C, 3JNHK at 25‡C,
and NH temperature coe⁄cients. Ordering information is giv-
en on any current masthead page.
Supporting information for micro¢lm edition
MARP 1H chemical shifts at 15‡C in 50 mm phosphate bu¡er at
pH 4.2
Residue NH
(ppm)
HK
(ppm)
HL
(ppm)
Other (ppm)
Cys-1 8.00 5.00 3.12,
2.81
Val-2 8.92 4.18 1.94,
2.08
CHQ3 0.91, 0.80
Arg-3 8.91 4.01 1.67,
1.95
HQ1.69, 1.82, HN 3.24 3.26,
NH 7.31
Leu-4 8.13 3.72 1.34,
1.54
HQ1.03, CHN3 0.79
His-5 8.99 4.25 3.70
3.42
HN 7.22, HO8.51
Glu-6 8.04 4.66 2.16 HQ2.24
Ser-7 8.63 4.68 3.84
Cys-8 8.08 4.96 3.57
3.13
Leu-9 7.92 4.08 1.57,
1.44
HQ1.44, CHN30.82
Gly-10 8.78 4.07,
3.69
Gln-11 8.06 4.24 1.95 HQ2.28, HO2 6.86, 7.49
Gln-12 8.68 4.27 2.20,
1.95
HQ2.30, 2.34, HO2 6.82, 7.45
Val-13 7.48 4.47 2.05 CHQ30.79, 0.90
Pro-14 8.81 4.55 2.25,
1.99
HQ1.84, 1.99, HN3.65, 3.77
Cys-15 4.92 3.35,
2.74
Cys-16 9.58 4.22 2.62,
3.17
Asp-17 8.19 4.78 2.63
2.41
Pro-18 8.88 4.50 2.35 HQ1.98, HN3.89, 4.04
Cys-19 4.72 2.94,
3.47
Ala-20 8.01 4.94 1.26
Thr-21 8.76 4.58 4.00 CHQ31.16
Cys-22 8.94 4.58 2.94,
3.02
Tyr-23 8.71 4.62 2.79 HN6.93 HO 6.74
Cys-24 8.30 4.91 3.23,
2.60
Arg-25 8.29 3.84 1.83,
1.55
HQ1.56, 1.23, HN3.06
Phe-26 7.91 4.74 2.80,
3.32
HN7.26 HO 7.42
Phe-27 8.54 4.19 3.12,
3.02
HN7.17, HO7.33
Asn-28 8.48 4.20 2.39,
2.77
HN2 6.66, 7.30
Ala-29 7.75 4.38 1.25
Phe-30 8.38 4.21 3.32,
3.36
Cys-31 8.34 5.63 2.59,
3.03
Tyr-32 8.88 5.20 2.59,
2.81
HN6.92, HO 6.66
Cys-33 8.19 4.96 3.21,
2.66
Arg-34 9.43 4.75 1.83,
1.70
HQ1.57, 1.69, HN2.62, 2.88,
NH 7.08
Lys-35 9.09 4.47 1.82,
1.68
HQ1.25, 1.43, HN1.64, HO2.89
Leu-36 8.77 4.3640 1.63 HQ1.52, CHN30.82, 0.70
Gly-37 8.48 4.09,
4.01
Thr-38 7.82 4.42 4.42 CHQ31.21
Ala-39 8.53 4.16 1.42
Met-40 8.06 4.40 1.95,
2.09
HQ2.51, 2.62
Asn-41 7.74 5.00 2.62,
2.81
HN2 7.67, 6.95
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MARP 1H chemical shifts at 15‡C in 50 mm phosphate bu¡er at
pH 4.2
Residue NH
(ppm)
HK
(ppm)
HL
(ppm)
Other (ppm)
Pro-42 8.68 4.47 2.29 HQ1.94, HN3.61, 3.67
Cys-43 4.59 3.22,
3.13
Ser-44 8.37 4.46 3.86
Arg-45 8.26 4.43 1.93,
1.75
HQ1.66, HN3.21, NH 7.25
Thr-46 7.86 4.15 4.23 CHQ31.15
MARP coupling constants at 25‡C and NH temperature coe⁄cients
in 50 mm phosphate bu¡er at pH 4.2
Residue 3JNHK coupling
constant (Hz)
NH temperature
coe⁄cient (ppb/‡C)
Cys-1 6.93
Val-2 8.79 3.63
Arg-3 7.00 6.37
Leu-4 5.64 3.47
His-5 7.50 2.58
Glu-6 9.34 2.90
Ser-7 5.86
Cys-8 9.92 3.84
Leu-9 4.40 2.43
Gly-10 7.06
Gln-11 8.14 4.94
Gln-12 8.00 4.38
Val-13 9.03 5.56
Pro-14 0.00
Cys-15 4.33 6.74
Cys-16 5.42 3.10
Asp-17 4.81
Pro-18 0.00
Cys-19 8.81 3.84
Ala-20 9.64 3.23
Thr-21 9.36 4.04
Cys-22 5.76 7.56
Tyr-23 2.01
Cys-24 3.14
Arg-25 5.90 2.93
Phe-26 8.70 3.67
Phe-27 3.68 6.21
Asn-28 7.82 5.66
Ala-29 7.56 2.10
Phe-30 7.59 4.84
Cys-31 9.17 5.84
Tyr-32 9.49 4.43
Cys-33 1.13
Arg-34 9.34 2.74
Lys-35 7.25 8.80
Leu-36 7.74 6.43
Gly-37 7.00
Thr-38 8.07 2.07
Ala-39 4.48 7.67
Met-40 7.50 2.98
Asn-41 8.19 1.08
Pro-42 0.00
Cys-43 7.24 7.86
Ser-44 7.26 8.38
Arg-45 7.54 4.47
Thr-46 4.61
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